Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Cancer
|
December 15, 1980
Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival
H M Shaw, V J McGovern, G W Milton, et al.
Cancer
|
April 1, 1980
Histologic features of tumors and the female superiority in survival from malignant melanoma
H M Shaw, V J McGovern, G W Milton, et al.
Biochemical and Biophysical Research Communications
|
September 16, 1992
Inhibition of DNA binding by the phosphorylation of poly ADP-ribose polymerase protein catalysed by protein kinase C
P I Bauer, G Farkas, L Buday, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2016
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
A Drilon, G Li, S Dogan, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Cancer
|
December 15, 1980
Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival
H M Shaw, V J McGovern, G W Milton, et al.
Cancer
|
April 1, 1980
Histologic features of tumors and the female superiority in survival from malignant melanoma
H M Shaw, V J McGovern, G W Milton, et al.
Biochemical and Biophysical Research Communications
|
September 16, 1992
Inhibition of DNA binding by the phosphorylation of poly ADP-ribose polymerase protein catalysed by protein kinase C
P I Bauer, G Farkas, L Buday, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2016
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
A Drilon, G Li, S Dogan, et al.
Page
of 2